AmplifyMD Names Stephen Klasko and Rod Hochman to Board and Advisory Team

AmplifyMD Names Stephen Klasko and Rod Hochman to Board and Advisory Team

AI-TechPark
AI-TechParkJan 12, 2026

Why It Matters

The appointments signal strong validation of AmplifyMD’s AI‑driven model and accelerate hospital adoption of integrated virtual specialty care, a critical lever for addressing clinician shortages.

Key Takeaways

  • AmplifyMD secured $20M Series B financing.
  • Stephen Klasko joins board, bringing health system expertise.
  • Rod Hochman becomes strategic advisor for virtual care expansion.
  • AI-driven specialty care seen as essential workforce solution.
  • Hospitals aim to embed virtual care into EHR workflows.

Pulse Analysis

The virtual care market is undergoing a fundamental transformation, moving beyond ad‑hoc telehealth visits toward fully integrated, AI‑enhanced platforms that sit directly within electronic health records. Health systems are seeking solutions that can extend specialist expertise without adding headcount, a need amplified by ongoing clinician shortages and rising patient demand for timely specialty access. AmplifyMD’s technology addresses this gap by automating referral routing, triage, and follow‑up, positioning the company at the forefront of the next wave of digital health innovation.

Adding Stephen Klasko and Rod Hochman to AmplifyMD’s governance and advisory ranks provides the company with unparalleled credibility and strategic insight. Both leaders have steered large, complex health systems through digital transformation, giving AmplifyMD direct access to executive perspectives on scaling virtual specialty services. Their involvement also reassures potential hospital partners that the platform aligns with broader system goals, such as improving care coordination, reducing burnout, and meeting value‑based reimbursement metrics.

Looking ahead, AmplifyMD is poised to capitalize on the growing consensus that AI‑driven virtual specialty care is a core component of health‑system strategy. With fresh capital, seasoned leadership, and a clear value proposition, the company can accelerate national expansion, forge deeper partnerships, and influence industry standards for integrated virtual care. As more hospitals embed such solutions into their EHR ecosystems, AmplifyMD’s model could become a benchmark for resilient, scalable specialty delivery in the post‑pandemic era.

AmplifyMD Names Stephen Klasko and Rod Hochman to Board and Advisory Team

Comments

Want to join the conversation?

Loading comments...